Point-of-care testing improves care timeliness in the emergency department. A multicenter randomized clinical trial (study POCTUR)
-
Antonio Leon-Justel
, Carmen Navarro Bustos
, Maria Dolores Aviles Gomez
Abstract
Objectives
Emergency department (ED) crowding is a widespread problem that positions patients at risk. The desire to improve the ED throughput requires novel approaches. Point-of-care testing (POCT) has emerged as useful technology that could contribute to create more efficient patient flow and better timeliness in the ED. The main objective of our study is to demonstrate, in a multicenter study, that POCT benefits care timeliness in the ED.
Methods
We conducted a multicenter and cluster randomized study. A total of 3,200 patients. We randomly assigned patients to a POCT group or Central Laboratory Group. The primary outcome was the ED time to clinical decision. The secondary outcome included the length of stay and the laboratory turnaround time. Readmission within the seven after discharge was also calculated.
Results
The primary finding of this study is a strategy based on POCT that aims to significantly improve care timeliness in the ED. We found significant reductions in all outcomes regardless of presentation reason, patient disposition or hospital type. Time to clinical decision decreased by 75.2 min (205–129.8), length of stay by 77.5 min (273.1–195.6) and laboratory turnaround time by 56.2 min (82.2–26) in the POCT group. No increase in readmission was found.
Conclusions
Our strategy represents a good approach to optimize timeliness in the ED. It should be seen as a starting point for further operational research focusing on POCT for improving throughput and reducing crowding in the ED.
Funding source: Instituto de Salud Carlos III
Award Identifier / Grant number: PI21/00829
-
Research ethics: The study titled “Design and validation of a single-act model based on point-of-care testing technology to improve emergency resolution in hospitals in the province of Seville”, a multicenter project of the University Hospitals Virgen del Rocío, Macarena, Valme and Osuna (sponsor code PI21/00829, internal code 1306-N-21), was evaluated and approved by the Research Ethics Committee (CEI) of the University Hospitals Virgen Macarena and Virgen del Rocío at their meeting on 02/17/2022 (minutes CEI_02/2022), after reviewing protocol version 1 dated 05/28/2021, with the sponsor being an investigator, and the study was conducted in accordance with the principles of the Declaration of Helsinki (2013 revision).
-
Informed consent: Not applicable.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission. Leon-Justel, Antonio: leads the overall impact assessment of the project, writes the initial manuscript, and oversees patient inclusion. Participates in the initial situation analysis and budget evaluation. Navarro, Carmen: Responsible for the initial situation analysis, implementation of tools, and writing of methodology at the Virgen Macarena Hospital. Coordinates patient inclusion and participates in the design of workflows. Noval-Padillo, JA: project coordinator at the Virgen del Rocio Hospital. Leads the design and development of the POCT platform and participates in impact and budget evaluations. Martin Perez, Salomon: main responsible for the statistical analysis of the study, development and maintenance of multicenter databases, coordination of the standardization of tests between participating hospitals. Preparation of the analysis and interpretation of data, preparation of tables and figures of the manuscript, and critical review of the statistical content of the article. Aviles Gomez, Maria Dolores: responsible for the coordination in the emergency service at the Virgen del Rocio Hospital. Contributes to the analysis of results, critical review and methodological validation. Jimenez Valencia, Nelia: contributes to the analysis of results, critical review and methodological validation. Garrido Castilla, Jose Manuel: responsible for the coordination of the emergency service at the Virgen Macarena hospital. Contributes to the analysis of results, critical review and methodological validation. Diaz Muñoz, Miguel: contributes to the analysis of results, critical review and methodological validation. Rivera Vizcaino, Maria A: contributes to the analysis of results, critical review and methodological validation. Alvarez Heredia, Laura: contributes to the analysis of results, critical review and methodological validation. Gracia Moreno, Emilia: coordinates the evaluation of professional satisfaction, contribution to the results section and statistical analysis of impact. Roldan, M. Esther: responsible at the Hospital de La Merced de Osuna for the analysis of the initial situation, implementation of tools and drafting of the methodology. Coordinates patient inclusion and participates in the design of workflows. Bueno Mariscal, Claudio: responsible for the initial situation analysis, implementation of tools and drafting of methodology at the Virgen de Rocio Hospital. Coordinates patient inclusion and participates in the design of workflows. Jimenez-Barragan, Marta: contributes to the analysis of results, critical review and methodological validation. Morales Barroso, Isabel: contributes to the analysis of results, critical review and methodological validation. Guerrero, Juan Miguel: contributes to the analysis of results, critical review and methodological validation. Sánchez-Mora, Catalina: Co-directs the design of the POCT platform, drafting of the methods section and assessment of care impact. Contributes to the analysis of results, critical review and methodological validation.
-
Use of Large Language Models, AI and Machine Learning Tools: None declared.
-
Conflict of interest: The authors state no conflict of interest.
-
Research funding: This research has been funded by the Instituto de Salud Carlos III (ISCIII) through the project “PI21/00829” and co-funded by the European Union (EU).
-
Data availability: Not applicable.
References
1. Di Somma, S, Zampini, G, Vetrone, F, Soto-Ruiz, KM, Magrini, L, Cardelli, P, et al.. Opinion paper on utility of point-of-care biomarkers in the emergency department pathways decision making. Clin Chem Lab Med 2014;52:1401–7. https://doi.org/10.1515/cclm-2014-0267.Search in Google Scholar PubMed
2. Pines, JM, Griffey, RT. What we have learned from a decade of ED crowding research. Acad Emerg Med 2015;22:985–7. https://doi.org/10.1111/acem.12716.Search in Google Scholar PubMed
3. Crowding in the Emergency Department: revised edition (June 2014). London: The College of Emergency Medicine; 2014. https://www.stemlynsblog.org/wp-content/uploads/2014/12/CEM6296-Crowding-1.pdf (Accessed 15 Dec 2023).Search in Google Scholar
4. Hing, E, Bhuiya, F. Wait time for treatment in hospital emergency departments: 2009. NCHS Data Brief 2012;102:1–8.Search in Google Scholar
5. Handel, D, Epstein, S, Khare, R, Abernethy, D, Klauer, K, Pilgrim, R, et al.. Interventions to improve the timeliness of emergency care. Acad Emerg Med 2011;18:1295–302. https://doi.org/10.1111/j.1553-2712.2011.01230.x.Search in Google Scholar PubMed
6. Morley, C, Unwin, M, Peterson, GM, Stankovich, J, Kinsman, L. Emergency department crowding: a systematic review of causes, consequences and solutions. PLoS One 2018;13:e0203316. https://doi.org/10.1371/journal.pone.0203316.Search in Google Scholar PubMed PubMed Central
7. Li, L, Georgiou, A, Vecellio, E, Eigenstetter, A, Toouli, G, Wilson, R, et al.. The effect of laboratory testing on emergency department length of stay: a multihospital longitudinal study applying a cross-classified random-effect modeling approach. Acad Emerg Med 2015;22:38–46. https://doi.org/10.1111/acem.12565.Search in Google Scholar PubMed PubMed Central
8. Leon-Justel, A, Alvarez-Rios, AI, Noval-Padillo, JA, Gomez-Bravo, MA, Porras, M, Gomez-Sosa, L, et al.. Point-of-care haemostasis monitoring during liver transplantation is cost effective. Clin Chem Lab Med 2019;57:883–90. https://doi.org/10.1515/cclm-2018-0889.Search in Google Scholar PubMed
9. Leon-Justel, A, Noval-Padillo, JA, Alvarez-Rios, AI, Mellado, P, Gomez-Bravo, MA, Álamo, JM, et al.. Point-of-care haemostasis monitoring during liver transplantation reduces transfusion requirements and improves patient outcome. Clin Chim Acta 2015;446:277–83. https://doi.org/10.1016/j.cca.2015.04.022.Search in Google Scholar PubMed
10. Storrow, AB, Zhou, C, Gaddis, G, Han, JH, Miller, K, Klubert, D, et al.. Decreasing lab turnaround time improves emergency department throughput and decreases emergency medical services diversion: a simulation model. Acad Emerg Med 2008;15:1130–5. https://doi.org/10.1111/j.1553-2712.2008.00181.x.Search in Google Scholar PubMed
11. Kankaanpää, M, Raitakari, M, Muukkonen, L, Gustafsson, S, Heitto, M, Palomäki, A, et al.. Use of point-of-care testing and early assessment model reduces length of stay for ambulatory patients in an emergency department. Scand J Trauma Resuscitation Emerg Med 2016;24:125. https://doi.org/10.1186/s13049-016-0319-z.Search in Google Scholar PubMed PubMed Central
12. Rooney, KD, Schilling, UM. Point-of-care testing in the overcrowded emergency department – can it make a difference? Crit Care 2014;18:692. https://doi.org/10.1186/s13054-014-0692-9.Search in Google Scholar PubMed PubMed Central
13. Ryan, RJ, Lindsell, CJ, Hollander, JE, O’Neil, B, Jackson, R, Schreiber, D, et al.. A multicenter randomized controlled trial comparing central laboratory and point-of-care cardiac marker testing strategies: the disposition impacted by serial point of care markers in acute coronary syndromes (DISPO-ACS) trial. Ann Emerg Med 2009;53:321–8. https://doi.org/10.1016/j.annemergmed.2008.06.464.Search in Google Scholar PubMed
14. Jimenez-Barragan, M, Rodriguez-Oliva, M, Sanchez-Mora, C, Navarro-Bustos, C, Fuentes-Cantero, S, Martin-Perez, S, et al.. Emergency severity level-3 patient flow based on point-of-care testing improves patient outcomes. Clin Chim Acta 2021;523:144–51. https://doi.org/10.1016/j.cca.2021.09.011.Search in Google Scholar PubMed
15. American College of Emergency Physicians. ACEP policy statements: triage scale standardization; 2010. Available from: http://www.acep.org/Content.aspx?id=29828&terms=triage%scale.Search in Google Scholar
16. Leon-Justel, A, Noval-Padillo, JA, Polonio, F, Gomez-Cia, T, Hinojosa, R, Porras, M, et al.. Mobile laboratory unit: a disruptor solution for hemostasis management during major surgery. Usage in the context of face transplantation. Clin Chem Lab Med 2012;50:1621–4. https://doi.org/10.1515/cclm-2011-0764.Search in Google Scholar PubMed
17. Giannitsis, E, Clifford, P, Slagman, A, Ruedelstein, R, Liebetrau, C, Hamm, C, et al.. Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry. BMJ Open 2019;9:e028311. https://doi.org/10.1136/bmjopen-2018-028311.Search in Google Scholar PubMed PubMed Central
18. Singer, AJ, Ardise, J, Gulla, J, Cangro, J. Point-of-care testing reduces length of stay in emergency department chest pain patients. Ann Emerg Med 2005;45:587–91. https://doi.org/10.1016/j.annemergmed.2004.11.020.Search in Google Scholar PubMed
19. Alter, DN. Point-of-care testing for the emergency department patient: quantity and quality of the available evidence. Arch Pathol Lab Med 2021;145:308–19. https://doi.org/10.5858/arpa.2020-0495-ra.Search in Google Scholar
20. Goyder, C, Tan, PS, Verbakel, J, Ananthakumar, T, Lee, JJ, Hayward, G, et al.. Impact of point-of-care panel tests in ambulatory care: a systematic review and meta-analysis. BMJ Open 2020;10:e032132. https://doi.org/10.1136/bmjopen-2019-032132.Search in Google Scholar PubMed PubMed Central
21. Arya, R, Wei, G, McCoy, JV, Crane, J, Ohman-Strickland, P, Eisenstein, RM. Decreasing length of stay in the emergency department with a split emergency severity Index 3 patient flow model. Acad Emerg Med 2013;20:1171–9. https://doi.org/10.1111/acem.12249.Search in Google Scholar PubMed
22. Goodacre, SW. Point-of-care testing may reduce length of stay but not emergency department crowding. Ann Emerg Med 2013;61:153–4. https://doi.org/10.1016/j.annemergmed.2012.09.001.Search in Google Scholar PubMed
23. Lee, EJ, Shin, SD, Song, KJ, Kim, SC, Cho, JS, Lee, SC, et al.. A point-of-care chemistry test for reduction of turnaround and clinical decision time. Am J Emerg Med 2011;29:489–95. https://doi.org/10.1016/j.ajem.2009.11.020.Search in Google Scholar PubMed
24. Kendall, J, Reeves, B, Clancy, M. Point of care testing: randomised controlled trial of clinical outcome. BMJ 1998;316:1052–7. https://doi.org/10.1136/bmj.316.7137.1052.Search in Google Scholar PubMed PubMed Central
25. Kheirbek, RE, Beygi, S, Zargoush, M, Alemi, F, Smith, AW, Fletcher, RD, et al.. Causal analysis of emergency department delays. Qual Manag Health Care 2015;24:162–6. https://doi.org/10.1097/qmh.0000000000000067.Search in Google Scholar
26. Kacprzyk, A, Stefura, T, Chłopaś, K, Trzeciak, K, Załustowicz, A, Rubinkiewicz, M, et al.. Analysis of readmissions to the emergency department among patients presenting with abdominal pain. BMC Emerg Med 2020;20:37. https://doi.org/10.1186/s12873-020-00334-x.Search in Google Scholar PubMed PubMed Central
27. Brennan, J, Chan, T, Killeen, J, Castillo, E. Inpatient readmissions and emergency department visits within 30 days of a hospital admission. West J Emerg Med 2015;16:1025–9. https://doi.org/10.5811/westjem.2015.8.26157.Search in Google Scholar PubMed PubMed Central
28. Plebani, M, Nichols, JH, Luppa, PB, Greene, D, Sciacovelli, L, Shaw, J, et al.. Point-of-care testing: state-of-the art and perspectives. Clin Chem Lab Med 2025;63:35–51.10.1515/cclm-2024-0675Search in Google Scholar PubMed
Supplementary Material
This article contains supplementary material (https://doi.org/10.1515/cclm-2024-1040).
© 2024 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- Are the benefits of External Quality Assessment (EQA) recognized beyond the echo chamber?
- Reviews
- Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part I – EQA in general and EQA programs in particular
- Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part II – EQA cycles
- Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part III – EQA samples
- Behind the scenes of EQA–characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part IV – Benefits for participant laboratories
- Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part V – Benefits for stakeholders other than participants
- Opinion Papers
- Not all biases are created equal: how to deal with bias on laboratory measurements
- Krebs von den Lungen-6 (KL-6) as a diagnostic and prognostic biomarker for non-neoplastic lung diseases
- General Clinical Chemistry and Laboratory Medicine
- Evaluation of performance in preanalytical phase EQA: can laboratories mitigate common pitfalls?
- Point-of-care testing improves care timeliness in the emergency department. A multicenter randomized clinical trial (study POCTUR)
- The different serum albumin assays influence calcium status in haemodialysis patients: a comparative study against free calcium as a reference method
- Measurement of 1,25-dihydroxyvitamin D in serum by LC-MS/MS compared to immunoassay reveals inconsistent agreement in paediatric samples
- Knowledge among clinical personnel on the impact of hemolysis using blood gas analyzers
- Quality indicators for urine sample contamination: can squamous epithelial cells and bacteria count be used to identify properly collected samples?
- Reference Values and Biological Variations
- Biological variation of cardiac biomarkers in athletes during an entire sport season
- Increased specificity of the “GFAP/UCH-L1” mTBI rule-out test by age dependent cut-offs
- Cancer Diagnostics
- An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumors
- Cardiovascular Diseases
- Comparative evaluation of peptide vs. protein-based calibration for quantification of cardiac troponin I using ID-LC-MS/MS
- Infectious Diseases
- The potential role of leukocytes cell population data (CPD) for diagnosing sepsis in adult patients admitted to the intensive care unit
- Letters to the Editor
- Concentrations and agreement over 10 years with different assay versions and analyzers for troponin T and N-terminal pro-B-type natriuretic peptide
- Does blood tube filling influence the Athlete Biological Passport variables?
- Influence of data visualisations on laboratorians’ acceptance of method comparison studies
- An appeal for biological variation estimates in deep immunophenotyping
- Serum free light chains reference intervals for the Lebanese population
- Applying the likelihood ratio concept in external quality assessment for ANCA
- A promising new direct immunoassay for urinary free cortisol determination
Articles in the same Issue
- Frontmatter
- Editorial
- Are the benefits of External Quality Assessment (EQA) recognized beyond the echo chamber?
- Reviews
- Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part I – EQA in general and EQA programs in particular
- Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part II – EQA cycles
- Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part III – EQA samples
- Behind the scenes of EQA–characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part IV – Benefits for participant laboratories
- Behind the scenes of EQA – characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part V – Benefits for stakeholders other than participants
- Opinion Papers
- Not all biases are created equal: how to deal with bias on laboratory measurements
- Krebs von den Lungen-6 (KL-6) as a diagnostic and prognostic biomarker for non-neoplastic lung diseases
- General Clinical Chemistry and Laboratory Medicine
- Evaluation of performance in preanalytical phase EQA: can laboratories mitigate common pitfalls?
- Point-of-care testing improves care timeliness in the emergency department. A multicenter randomized clinical trial (study POCTUR)
- The different serum albumin assays influence calcium status in haemodialysis patients: a comparative study against free calcium as a reference method
- Measurement of 1,25-dihydroxyvitamin D in serum by LC-MS/MS compared to immunoassay reveals inconsistent agreement in paediatric samples
- Knowledge among clinical personnel on the impact of hemolysis using blood gas analyzers
- Quality indicators for urine sample contamination: can squamous epithelial cells and bacteria count be used to identify properly collected samples?
- Reference Values and Biological Variations
- Biological variation of cardiac biomarkers in athletes during an entire sport season
- Increased specificity of the “GFAP/UCH-L1” mTBI rule-out test by age dependent cut-offs
- Cancer Diagnostics
- An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumors
- Cardiovascular Diseases
- Comparative evaluation of peptide vs. protein-based calibration for quantification of cardiac troponin I using ID-LC-MS/MS
- Infectious Diseases
- The potential role of leukocytes cell population data (CPD) for diagnosing sepsis in adult patients admitted to the intensive care unit
- Letters to the Editor
- Concentrations and agreement over 10 years with different assay versions and analyzers for troponin T and N-terminal pro-B-type natriuretic peptide
- Does blood tube filling influence the Athlete Biological Passport variables?
- Influence of data visualisations on laboratorians’ acceptance of method comparison studies
- An appeal for biological variation estimates in deep immunophenotyping
- Serum free light chains reference intervals for the Lebanese population
- Applying the likelihood ratio concept in external quality assessment for ANCA
- A promising new direct immunoassay for urinary free cortisol determination